SIRT2 ablation has no effect on tubulin acetylation in brain, cholesterol biosynthesis or the progression of Huntington's disease phenotypes in vivo.

Cited by papers we hold 6

• SIRT1 and SIRT2 Activity Control in Neurodegenerative Diseases · 2021
  No notice
• Sirtuins and their Biological Relevance in Aging and Age-Related Diseases · 2020
  No notice
• Neurobiology of axonal transport defects in motor neuron diseases: Opportunities for translational research? · 2017
  No notice
• Selective Sirt2 inhibition by ligand-induced rearrangement of the active site · 2015
  No notice
• HDAC4 Reduction: A Novel Therapeutic Strategy to Target Cytoplasmic Huntingtin and Ameliorate Neurodegeneration · 2013
  No notice
• SIRT1 and SIRT2: emerging targets in neurodegeneration · 2013
  No notice

Reads

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.